The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
1. A molecule that allows on to stop neovascular armd to form from dry armd 2. A product with a potentially large market share compared to the current agents available 3. A compound that could have a sustained drug delivery module
This article reveals what has been known on an "anecdotal" basis for a very long time in the arena of ophthalmic correction. While the increasing availability of designs in multifocal implants is a welcome addition to the surgeon's armamentarium, much as it is in the field of contact lens correction...
Contact lens patients are starting to wonder what contact lens solutions are safe anymore. After last year's ReNu with MoisturLoc (Bausch & Lomb) worldwide recall due to a fungal infection; and now, Complete MoisturePlus (Advanced Medical Optics) has been recalled worldwide due to an increased...
The FDA has just approved a "bifocal LASIK" technique from Advanced Medical Optics using their CustomVue Excimer laser platform. It has been approved as " a new device". In actuality, it is neither a new device nor does it provide bifocal vision.
This article is suggesting that it is a new procedure to allow a bifocal correction during lasik. The Bifocal Lasik undercorrects nearsightedness in one eye, essentially monovision. Monovision Lasik has been used for years to allow patients the ability to see distance and near without glasses,...
In this news release presented today, this leading ophthalmic journal reports that AMO has presented the highest bid for the purchase of Bausch and Lomb.
Dr Smiddy reviewed age-related macular degeneration studies to evaluate the cost for the visual benefit of various treatment approaches, and then compared them with the costs for treating other retinal conditions. This study founds costs for treating wet macular degeneation could be as high as $9000...